The Washington PostDemocracy Dies in Darkness

Business is booming for dialysis giant Fresenius. It took a bailout of at least $137 million anyway.

Half of the money the Trump administration gave dialysis companies was collected by a global firm headquartered in Germany with a robust balance sheet. It’s one of the bluntest examples yet of how the Department of Health and Human Services failed to direct taxpayer-supported bailout funds only to providers in crisis.

By
and 
August 5, 2020 at 1:13 p.m. EDT
The headquarters of Fresenius, a kidney-care company, in Bad Homburg, Germany. (Frank Rumpenhorst/Picture Alliance/DPA/AP)

As the novel coronavirus pandemic paralyzed most non-emergency medical practices this spring, the dialysis business rolled ahead and in some cases grew.

Yet when the Trump administration sent billions in federal relief funds to medical organizations, at least $259 million went to dialysis providers, a Kaiser Health News analysis of federal records found. Of that, kidney-care behemoth Fresenius Medical Care accepted more than half, at least $137 million, despite acknowledging it had ample financial resources, the analysis showed.